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High Prevalence of Hepatitis C Infection in a Brazilian Prison:
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Maria Lúcia G. Ferraz, Adauto Castelo and Esper Georges Kallás College - São paulo, SP, Brazil
Hepatitis C virus (HCV) causes infectious hepatitis worldwide. It is transmitted mainly by
blood products and sharing of intravenous paraphernalia during illicit drug use. High prevalence
rates have been described among specific groups considered to be at higher  risk for HCV
infection, including prison inmates. The objectives of this study were: to determine the HCV
seroprevalence among inmates of Casa de Detenção de São Paulo; to identify risk factors for HCV
infection; and to compare the seroprevalence of HCV to other blood borne or sexually transmitted
diseases. From December, 1993, to January, 1994, a total of 779 inmates were interviewed to
collect information on sociodemographic status, sexual behavior, and past experience with illicit
drugs. Blood samples were obtained from 756 inmates for serological tests. 310 (41%) blood
samples were positive for anti-HCV, 425 (56.2%) were negative, and 21 (2.8%) showed
indeterminate results. In this population, we found a seroprevalence of 13.7% for HIV, 3.3% for
syphilis (VDRL), and 68.1% for hepatitis B virus previous infection. Four variables were each
identified as associated with a positive anti-HCV serologic test: a positive VDRL (OR = 2.63 IC
95% 1.08 to 6.36); a time of current imprisonment longer than 130 months (OR = 2.44 IC 95%
1.04 to 5.71); previous incarceration at Casa de Detenção de São Paulo (OR = 1.73 IC 95% 1.19
to 2.52) and; illicit drug use before admission to the Casa de Detenção de São Paulo (OR = 1.64 IC
95% 1.15 to 2.33). The seroprevalence of HCV antibodies among the study population was high
(41%), indeed, one of the highest clusters of HCV infection recorded until now. Four variables
were each shown to be associated with HCV infection. The simultaneous presence of these 4
variables is associated with an 82% probability of being anti-HCV positive. Although risk factor
analysis indicates most HCV infections occur  prior to inprisonment, initiation of control measures
to prevent continued transmission after incarceration should be done.
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The hepatitis C virus (HCV) is one of the leading
causes of infectious hepatitis worldwide. The major
source of transmission is through blood transfusion and
its derivates. However, this route alone is not enough
to maintain the virus in humans [1]. Other routes are
implicated including sexual and perinatal transmission.
Percutaneous exposure also constitutes a risk factor
for HCV infection represented by intravenous drug
users, tattooing, and occupational exposure to blood.
It is very difficult to estimate the overall prevalence
of HCV infection in the general population, as most
studies have focused on selected groups with either
high or low risk for HCV infection. The correctional
population represents a selected group with high risk
behavioral practices, such as homosexuality and
intravenous drug use, associated to HCV transmission.
Few studies have been published analyzing its
prevelence in prisons. Some of these studies
demonstrated that HCV is a significant problem in
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prisons. The overall seropositivity of HCV in a
penitentiary in Ontario, Canada, was 39.8% [2], while
in Norway and Australia it was 57% and 54%,
respectively, among prisoners who reported intravenous
drug use [3, 4].
The purpose of this study was to determine the HCV
seroprevalence among male inmates from the Casa de
Detenção de São Paulo, to identify independent risk
factors associated with HCV infection, and to compare
the seroprevalence of HCV to other blood borne or
sexually transmitted diseases.
Materials and Methods
The Casa de Detenção in São Paulo includes a
section of Carandiru Complex constituted by 7
pavillions housing a variable number of male prisoners.
When the study began, the Casa de Detenção had
4,657 inmates. Sample size determination was based
on the total number of prisoners at the time of the study,
the HCV seroprevalence range of 10% to 40% (P), a
5% margin of error (d) for the total inmate population,
and a 95% confidence interval of a 4% error in the
final seroprevalence (n = Z21-a/2 P(1-P)/d
2). Assuming
a seroprevalence ranging from 10% to 40%, the
required sample size would vary from 216 to 576
inmates. A larger sample size of inmates was chosen.
Application of a questionnaire and blood collection
took place from December 20, 1993, to January 5,
1994. The number of inmates in each pavillion selected
to participate in the study was proportional to the total
distribution of inmates per pavillion. The questionnaire
gathered information regarding demographics, prison
history, and risk factors for HCV infection, obtained
after consent by the inmate. All data were kept
confidential. A blood sample was obtained by
venipuncture and serum separated and stored at -20°C.
HCV serology was performed using an
immunoenzymatic assay (INNOTEST HCV Ab III -
Innogenetics, Antwerp, Belgium). This test uses
synthetic peptides for the core, NS3, NS4, and NS5
regions. The samples with undetermined results were
submitted to an immunoblot assay (INNO-LIA HCV
Ab - Innogenetics, Antwerp, Belgium).
The samples were also tested for HIV, hepatitis B
virus (HBV), and syphilis. HIV serology was performed
using gelatin agglutination (Fujirebio Inc., Tokyo, Japan)
and fluorescence assay (bio Mérieux S.A., France and
bio Mérieux Vitek, Inc., USA). Syphilis serology was
performed using the Venereal Diseases Research
Laboratory (VDRL) and Treponema pallidum
hemagglutination assays (TPHA). HBV serology was
performed using a radio-immune assay for HBsAg test
(CIAE HBsAg SPRIA Kit - Department of Isotope -
China Institute of Atomic Energy). The inmates who
had positive HBsAg samples were considered to have
chronic HBV infection and the HBsAg negative or
indeterminate samples were submitted to anti-HBs
antibody detection (CIAE Anti-HBs SPRIA Kit -
Isotope Department - China Institute of Atomic
Energy). HIV serology results were previously
published elsewhere.
Data collection was performed using Epi Info
Software, version 5.1b (World Health Organization and
Centers for Disease Control and Prevention). Statistical
analysis was performed using BMDP Statistical
Software. Statistical significance was considered for p
values less than 0.05 in univariate analysis and 0.1 in
multivariate analysis.
Results
During the study period, 779 questionnaires with
corresponding serum samples were obtained. Twenty-
three individuals were excluded because the amount of
blood obtained was insufficient. After these exclusions,
data from 756 inmates were available for HCV testing.
The mean age was 30.2 years (median 28 years).
There were 56.8% (442) whites, 26.2% (205)
mulattos, and 16.9% (132) blacks. HCV serology was
negative in 425 (56.2%), positive in 310 (41.0%) and
indeterminate in 21 (2.8%).
Sexual behavior
Regarding sexual activity before admission to the
Casa de Detenção, 650 participants (83.4%) claimed
to have engaged in only heterosexual behavior, 118
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(15.2%) admitted homosexual practices, and 11
(1.4%) denied any sexual practice in their lifetime. After
admission to the Casa de Detenção, these same sexual
behaviors were practiced by 353 (45.2%), 91 (11.7%),
and 335 (43.1%), respectively. The majority denied
any previous condom use (714, 91.7%).
In the year before admission to the Casa de
Detenção, 12 (1.5%) denied any sexual practice, 572
(73.5%) had 1 to 4 sexual partners, and 195 (25.0%)
had 5 or more partners. Once inside the Casa de
Detenção, 342 (43.9%) had no sexual partner, 364
(46.7%) had one sexual partner and 73 (9.4%) had 2
or more sexual partners.
Illicit drug use
Before admission to the Casa de Detenção, 576
inmates admitted illicit drug use: 431 (55.4%) reported
only inhaled or oral drug use; and 145 (18.6%) reported
previous intravenous drug use; 408 inmates (51.6%)
reported illicit drug use inside Casa de Detenção, but
only 11 (1.4%) were intravenous users.
Results of serology of other bloodborne or sexually
transmitted diseases.
The overall serological results are presented in Table
1. The data on HIV seroprevalence and risk factors
for its acquisition were previously reported [5].
Risk Factors for HCV infection
Univariate analysis was performed initially to evaluate
several variables included in the questionnaire. Five
variables were identified as significantly associated with
HCV infection: 1) younger age (mean age among HCV
seronegative inmates = 29.5 years; mean age among
HCV seropositive inmates = 30.6 years; mean age
among indeterminate results = 32.0; p=0.04); 2)
previous imprisonment in Casa de Detenção; 3) time
of current imprisonment; 4) prior admission to
FEBEM (a correctional facility for offenders under
18 years old); and 5) illicit drug use before and after
the actual imprisonment.
Among 144 inmates that admitted illicit intravenous
drug use before admission to the Casa de Detenção,
the difference in seropositivity for HCV infection among
those who shared syringes (48.1%) was not statistically
significant from those who did not (40.1%; p=0.39).
Therefore, the sharing of intravenous paraphernalia was
not related to HCV serostatus among those who
reported illicit drug use.
Two other variables were also identified as
associated with HCV infection: 1) presence of anti-
HIV antibodies (p=0,007); and 2) a positive VDRL
test (p=0.04). The association between HCV
seropositivity and the other serological tests performed
is shown in Table 2.
The independent contribution of each of these risk
factors was assessed by stepwise logistic regression
multivariate analysis. To categorize the continuous
variables, the age was divided into two halves (<29
years old or equal or >29 years old), and the time
of current imprisonment was divided into >130
months and ≤130 months. Only time of current
imprisonment, history of previous imprisonment in
Casa de Detenção, positive VDRL, and illicit drug
use before admission to Casa de Detenção
maintained positive independent association with
HCV seropositivity. The summary of the multivariate
analysis is shown in Table 3.
Table 4 lists the chances of being anti-HCV positive
in accordance with presence or absence of the 4
variables independently associated with HCV infection.
The simultaneous presence of these 4 variables is
associated with a probability of 82% to be anti-HCV
positive. On the other hand, the absence of these
variables is associated with a probability of 30% to be
seropositive for HCV.
Discussion
The data presented in this study highlight many of
the current issues and concerns about the transmission
of HCV in prisons. The seroprevalence observed in
the Casa de Detenção (41%) was considered higher
when compared with the general population where the
seropositivity for HCV ranges from 0.2 to 1.5% [6].
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Table 1. Serological tests performed at Casa de Detenção de São Paulo for detection of HCV, HIV,
syphilis, and HBV
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Anti-HCV Anti-HIV VDRL TPHA HBsAg Anti-HBs
N 756 765 763 765 425 253
Negative 425 636 738 678 254 117
(56.2%) (83.0%) (96.7%) (88.6%) (59.8%) (46.2%)
Positive 310 105 25 87 130 95
(41.0%) (13.7%) (3.3%) (11.4%) (30.6%) (37.5%)
Indeterm. 21 24 0 0 41 41
(2.8%) (3.1%) (9.6%) (16.2%)
Table 2. Association between anti-HCV and HIV, syphilis, and HBV in study population
Serological test HCV HCV HCV P value
Negative Positive Indeterminate
N (%) N (%) N (%)
Anti-HIV:
   Negative 364 (58.2%) 236 (38.1%) 19 (3.1%)
   Positive 48 (46.2%) 54 (51.9%) 2 (1.9%) 0.007
   Indetermin. 8 (33.3%) 16 (66.7%) 0
VDRL:
   Negative 412 (57.0%) 291 (40.2%) 20 (2.8%)
   Positive 8 (32.0%) 16 (64.0%) 1 (4.0%) 0.04
   Indetermin. 0 (0%) 0 (0%) 0
HbsAg:
   Negative 148 (59.7%) 97 (39.1%) 3 (1.2%)
   Positive 60 (47.2%) 66 (52.0%) 1 (0.8%) 0.14
   Indetermin. 19 (48.7%) 20 (51.3%) 0 (0%)
Anti-HBs:
   Negative 63 (55.8%) 49 (43.4%) 1 (0.8%)
   Positive 57 (60.6%) 35 (37.2%) 2 (2.2%) 0.61
   Indetermin. 27 (65.9%) 14 (34.1%) 0 (0%)
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Table 3. Independent risk factors associated with positive anti-HCV, identified by multi-step logistic regression
multivariate analysis
Table 4. Likelihood of HCV infection estimated by multi-step logistic regression multivariate analysis
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Variable OR IC 95% - OR P value
Time of current 2.44 1.04-5.71 0.029
imprisonment > 130 months
Previous imprisonment 1.73 1.19-2.52 0.001
at Casa de Detenção
Positive VDRL 2.63 1.08-6.36 0.014
Illicit drug use before 1.64 1.15-2.33 0.006
incarceration in Casa de Detenção
Time of current imprisonment > 130 months
Drug use
Previous imprisonment Yes No
VDRL (+) (*) (*)
VDRL (-) 0.75 0.65
Without imprisonment
VDRL (+) 0.82 (*)
VDRL (-) 0.63 0.52
Time of current imprisonment ≤ 130 months
Drug use
Previous imprisonment Yes No
VDRL (+) 0.76 0.66
VDRL (-) 0.55 0.43
Without imprisonment
VDRL (+) 0.65 0.53
VDRL (-) 0.41 0.30
(*) Likelihood would not be estimated because there were no individuals in these
categories.
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A similar observation was made for the others diseases
studied here: 68.1% for HBV, 13.7% for HIV, and
3.3% for syphilis.
Identification of risk factors for HCV infection is
essential for the adoption of potentially beneficial control
strategies. Using univariate analysis, 7 variables were
identified to be significantly associated with HCV
infection: 1) younger age, 2) previous imprisonment in
Casa de Detenção, 3) time of current imprisonment,
4) prior imprisonment at young offenders facility, 5)
illicit drug use before and after the actual imprisonment,
6) presence of anti-HIV antibodies, and 7) a positive
VDRL test. However, only 4 of these were independent
risk factors by multi-step logistic regression multivariate
analysis: previous imprisonment at Casa de Detenção,
current imprisonment longer than 130 months, positive
VDRL test, and illicit drug use before admission to Casa
de Detenção.
The HCV seroprevalence observed in the
correctional population indicates that this specific group
is considered at risk for HCV infection. Several studies
performed in Australia also demonstrated high
prevalences: 39% in 1995 [7], and 37% in 1997 [8].
This prevalence may be atributted to the large number
of inmates with behavioral risk, mainly illicit drug use.
The HIV seroprevalence observed in the Casa de
Detenção places this institution among those with the
highest reported rates of HIV-1 infection. Noteworthy
is the fact that the incidence of 17.3% observed in 1990,
was even higher than in the present study performed in
1993 to 1994 (13.7%) [6]. A similar observation was
made in New York State prisons, where the
seroprevalence among male inmates was 17% in 1987
to 1988, 15% in 1990, and 12% in 1992. However, a
different pattern of seropositivity developed among
female inmates, with seroprevalence rates of 19% in
1988, and 20% in 1992 to 1993 (data obtained from
the New York State Department of Health) [9]. The
reasons for this decrease in HIV seroprevalence among
the male inmates is not yet well understood.
Since HIV and HCV have the same route of
transmission, we would expect that the impact of control
measures for HIV could also contribute to an expected
decrease in HCV transmission. However, HCV is not
only more prevalent than HIV among intravenous drug
users, but also has the greatest infectivity [10]. So it is
not surprising that these two conditions maintain a high
HCV seroprevalence among drug users. Finally, the
long latency of HCV (on average, more than 20 years)
would increase the likelihood of transmission when
compared with the latency of HIV (on average, less
than 10 years).
Previous history of sexually transmitted diseases
(STD), like syphilis and hepatitis B, was evaluated
through serological tests. The data that 43.9% of inmates
denied sexual practice after the admission at Casa de
Detenção, and that the great majority of them denied
any previous condom use, suggests that the inmates were
likely exposed to T. pallidum before admission to the
penitentiary. This seroprevalence is similar to that
observed among pregnant women in Brazil [11].
The HBV seropositivity was 37.5% for anti-HBs
and, unexpectedly, we found 30.6% to be HBsAg
positive. Some explanations for this finding should be
considered. First, false positive RIA results seems
unlikely, since the positive samples were strongly
reactive and the indeterminate results were confirmed
by another method (Auszyme Monoclonal - Abbot).
Second, a greater HBV exposition among the inmates.
Third, the presence of immune suppression associated
with drug use.
Analysis of risk factors
Age: The identification of age <28 years as an
independent risk factor in this study, could be the result
of either higher rate of illicit drug use or high risk sexual
activity among younger people. Despite educational
programs, younger people may be less susceptible to
prevention campaigns. In addition, young inmates may
be even less informed than young public school
students, as evidenced by higher rates of drug use and
unsafe sexual practices. Other studies have also shown
a higher rate of drug use among younger inmates [12].
In addition, the significant association of previous
imprisionment at a young offenders facility, and HCV
seropositivity, suggests that the inmates have an early
exposure to HCV.
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Drug use: Illicit drug use (intravenous or inhaled) is
clearly associated with HCV transmission by multi-step
logistic regression multivariate analysis (OR=1.64, CI 95%
1.15 - 2.33). The relationship between illicit drug use and
crime has been the subject of intense debate. It has been
suggested that drug use and prison experience are
interrelated. Intense illicit drug use drives illegal behavior
resulting in imprisonment; and high crime levels stimulate
illicit drug use. In this study, there was a high frequency of
illicit drug use prior to incarceration in the Casa de
Detenção (74%), demonstrating a rather high relationship
between crime and illicit drug use in this group.
HCV transmission through the parenteral route was
clearly established, and its transmission by blood
transfusions was virtually eliminated where there was
effective screening. However, this route of HCV
transmission is maintained due to the high prevelence
between drug users who share needles, syringes and
other contaminated equipment [13]. Therefore, it was
expected that the prevalence of blood borne pathogens
was higher in the inmate population.
Several studies have described intravenous drug use
inside correctional facilities as a risk factor for HCV
infection [14]. This may be partially explained by the
paucity of syringes and needles, and generally poor
hygienic conditions, all favoring the sharing and
reutilization of intravenous paraphernalia. Although
intravenous drug use was admitted by a minority of the
individuals in the Casa de Detenção, 55.4% admitted
the use of other types of illicit drugs inside the Casa de
Detenção. This high rate of drug use reported by the
inmates makes under reporting of intravenous drug use
inside the Casa de Detenção somewhat unlikely. It has
been noted that the intravenous drug use in this
correctional facility has markedly decreased due to the
difficulty of obtaining injection material, concern about
AIDS transmission, and the widespread use of crack
cocaine as opposed to intravenous cocaine.
The identification of inhalatory drug use as a risk
factor for HCV infection requires some consideration.
First, drug users who admitted inhalatory use, denied
intravenous use due to the fear of discrimination.
Second, HCV transmission by the inhalatory route was
recently described in drug addicts [15]. The proposed
mechanism would be epistaxis secondary to local
trauma by the equipment (straws), and sharing it with
other users.
Previous incarceration at Casa de Detenção de São
Paulo: This variable was also identified as an
independent risk factor for HCV infection (OR=1.73,
CI 95% 1.19 - 2.52). This association could be due to
higher rates of illicit drug use inside Casa de Detenção.
Müller, et al., stated that sharing needles outside prison
was not a risk factor for HCV infection. However, this
practice inside prison was considered an important risk
factor for both HIV and HCV infection [16].
Length of current imprisonment: The length of current
imprisonment of  >130 months was also an independent
risk factor for HCV infection (OR= 2.44, CI 95% 1.04
- 5.71), demonstrating that the longer the time in prison
the higher the likelihood of HCV infection. Some studies
reported that the continuous use of intravenous drugs
for more than 8 years was associated with 100% of
HCV seroprevalence, and the continuous use for more
than 2 years was associated with two thirds of HCV
seroprevalence [17]. In our study, there was a 44.2%
seropositivity to HCV among the inmates who admitted
drug use following admission to Casa de Detenção.
Therefore, it is not surprising that individuals
incarcerated for a longer time had 2.44 times greater
likelihood of being HCV positive.
Prior imprisonment at FEBEM: The FEBEM is a
correctional institution for young offenders. The
significant association between this variable with
seropositivity to HCV suggests that the inmates can be
exposed to HCV during their time in FEBEM, where
they probably have contact with illicit drugs. However,
this variable may be just a marker of other variables,
since it was not present as an independent risk factor
after stepwise logistic regression multivariate analysis.
Presence of anti-HIV antibodies: The presence of anti-
HIV antibodies as a risk factor was expected, since
both diseases share the same transmission routes.
However, differences in their infectivity seem to affect the
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transmission inside prisons. For HCV, the viral load is
constant making its parenteral transmission easy. The
association between HCV and HIV has been described
in several trials and may be more biological than behavioral
[18]. One explanation may be that the immunosuppression
caused by HIV facilitate HCV transmission [19].
Positive VDRL test: A positive VDRL test was also
identified as an independent risk factor for HCV infection
(OR= 2.63; CI 95% 1.08 - 6.36). This correlation
has been seen in groups who had hyperactive sexual
behavior, suggesting that the sexual route may be an
important contributor for HCV transmission [20].
Despite that sexual activity and the number of sexual
partners did not demonstrate significant association with
HCV infection, we believe that the risk of sexual
transmission may be higher in persons with genital
ulcers, as is the case in syphilis.
Epidemiological studies on the transmission of
blood-borne pathogens in this population are
important to better elucidate how efficient control
initiatives should take place.
Control of HCV transmission among prisoners is
desirable, considering that HCV is the cause of chronic
disease in the great majority of infected subjects with
unfavorable natural history. Clearly, it is a very difficult
goal to accomplish. Taking into account that a significant
number of inmates may have acquired HCV infection
before incarceration, the impact of control measures
would be limited, but is extremely important.
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